🇺🇸 FDA
Patent

US 6992096

1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

expired A61KA61K31/4245A61K31/4439

Quick answer

US patent 6992096 (1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease) held by PTC THERAPEUTICS, INC. expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Jan 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/4245, A61K31/4439, A61K31/454, A61K31/4545